Valeant Pharma (VRX) option implied volatility elevated into Q1 and outlook
Valeant Pharma (NYSE: VRX) May weekly call option implied volatility is at 117, May is at 80, June is at 55; compared to its 52-week range of 41 to 87 into the expected release of Q1 results before the open on May 8.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sk Telecom (SKM) call put ratio 1.7 calls 1 put on 9900 contracts
- Oracle (ORCL) spreader of September 165, March 170 and March 220 calls into quarter results
- Novartis (NVS) call put ratio 1.6 calls 1 put into share price lower before the bell
Create E-mail Alert Related Categories
Options, Trader TalkRelated Entities
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share